Search
Search
Close this search box.

Arkansas Law Seeking to Ban Delta-8 THC Challenged in New Lawsuit 

A new Arkansas law aiming to ban hemp-derived psychoactive cannabinoids including delta-8 THC is being challenged in court amid accusations it violates the 2018 Farm Bill.

Act 629 came into effect on August 1, 2023, effectively banning the production and sale of products containing delta-8, delta-9 and delta-10 THC and other variations of the cannabinoids inside the state of Arkansas.

The controversial act also includes provisions to regulate psychoactive, hemp derived products in the event that the proposed ban is overturned by the courts, meaning wholesalers distributors and retailers would be required to obtain a permit from local authorities costing $5000 per year.

Both the ban and this proposed regulatory plan are now being challenged by a group of four hemp businesses, who filed a lawsuit in the federal court in Little Rock on Monday, High Times reported.

READ MORE: MIRA Pharmaceuticals Launches on NASDAQ

The plaintiffs, Bio Gen, Drippers Vape Shop, The Cigarette Store (which trades as Smoker Friendly) and Sky Marketing Corporation (which trades as Hometown Hero), are calling for an injunction to block Act 629, arguing that it is not compatible with the US Constitution’s commerce and supremacy clauses and is a violation of the 2018 Farm Bill.

Cynthia Cabrera, chief strategy officer at Hometown Hero CBD, told High Times: “Businesses like Hometown Hero invested in Arkansas in part relying on the state’s declared public policy to position itself at ‘the forefront of industrial hemp production, development, and commercialization.’

“And overnight, Act 629 turned farmers into felons and retailers into drug dealers—all in violation of federal law. Ultimately, we would like to see reasonable regulation that allows businesses to grow and thrive while allowing adult consumers access to safe, legal hemp-derived products.”

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?